Jun 29, 2020
Dr. Berenson is the founder and Principal for the James R. Berenson, MD, Inc. dba Berenson Oncology, a unique multi-faceted business entity built around an established and integrated healthcare and biotech family of companies. These consist of:
Dr. Berenson has authored more than 300 peer-reviewed publications and contributed to multiple book chapters. He serves as a member of the National Institutes of Health – Center for Scientific Review, Clinical Oncology Study Section and is a member of the Scientific Boards of the Multiple Myeloma Research Foundation and the International Myeloma Foundation. Dr. Berenson serves on both the Foundation and the Scientific Boards of the Leukemia, Lymphoma and Myeloma Society.